Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof

Details for Australian Patent Application No. 2010237572 (hide)

Owner University Health Network

Inventors Liu, Fei-Fei; Ito, Emma; Kim, Inki

Agent FB Rice

Pub. Number AU-A-2010237572

PCT Pub. Number WO2010/118524

Priority 61/170,148 17.04.09 US; 61/170,145 17.04.09 US

Filing date 12 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/527 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving lyase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/118524 Priority application(s): WO2010/118524

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010237573-Signature of secreted protein isoforms specific to ovarian cancer

2010237569-Peptide ligands for clusterin and uses thereof